By: Joseph Walker
Pharma giant Eli Lilly said it is negotiating to raise drug prices in Europe, starting in the U.K. with the weight-loss drug Mounjaro, so that it can comply with the Trump administration's goal of bringing down prices in the U.S.


Joseph Walker is a Reporter at The Wall Street Journal. He covers a range of topics including pharma, biotech, consumer health, and mental health, with a particular focus on pharmaceutical manufacturing and regulation. Joseph's work has been featured in prominent publications such as The Globe and Mail, Reuters, and Yahoo Finance.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Joseph Walker's coverage is heavily focused on the health and healthcare industries, particularly regarding pharmaceutical companies, drug approvals, regulatory actions by government agencies like the FDA, and policy developments affecting drug prices. He has a specific focus on US-based news.
If you are reaching out to Joseph with a pitch or as a potential source, ensure that your expertise aligns with these areas of interest. Topics such as FDA approval processes for new drugs, investigations into health insurers' role in driving up drug costs, and industry responses to regulatory changes could be particularly relevant based on his recent articles.
Given his high percentage of press releases cited in coverage attributes (23%), providing access to exclusive data or insider perspectives related to major announcements from pharmaceutical companies or healthcare institutions may increase the likelihood of getting noticed by Joseph.
This information evolves through artificial intelligence and human feedback. Improve this profile .